| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 649269 | 61479 | ARTINIBSA 40 MG/ML + 10 MICROGRAMOS/ML SOLUCION INYECTABLE | ARTINIBSA 40 MG/ML + 10 MICROGRAMOS/ML SOLUCION INYECTABLE 100 cartuchos de 1,8 ml | 40 mg/ml + 10 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61479/61479_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61479/61479_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1997-04-01 | 1 | 1 | 1 | 1997-04-07 | 1997-04-07 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 606030 | 61480 | ARTINIBSA 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE | ARTINIBSA 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE 100 cartuchos de 1,8 ml | 40 mg/ml + 5 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61480/61480_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61480/61480_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1997-04-01 | 1 | 1 | 1 | 1997-04-07 | 2013-01-16 | 1 | 2014-04-05 | View Edit Delete | ||||||||||||
| 649277 | 61480 | ARTINIBSA 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE | ARTINIBSA 40 MG/ML + 5 MICROGRAMOS/ML SOLUCION INYECTABLE 100 cartuchos de 1,8 ml | 40 mg/ml + 5 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61480/61480_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61480/61480_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1997-04-01 | 1 | 1 | 1 | 1997-04-07 | 1997-04-07 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 672527 | 61488 | ULTIVA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 1 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 1 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61488/61488_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61488/61488_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 672519 | 61489 | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 2 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 2 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61489/61489_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61489/61489_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 672501 | 61490 | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION | ULTIVA 5 mg POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION , 5 viales | 5 mg | 45 | 5 | 34 | 5 viales | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61490/61490_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61490/61490_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 13382 | ASPEN PHARMACARE ESPANA S.L. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 0 | 2012-01-02 | Lista I | View Edit Delete | |||||||||||
| 649483 | 61492 | ATENOLOL NORMON 50 mg COMPRIMIDOS RECUBIERTOS EFG | ATENOLOL NORMON 50 mg COMPRIMIDOS RECUBIERTOS EFG , 500 comprimidos | 50 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61492/61492_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61492/61492_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 1997-09-01 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 716084 | 61492 | ATENOLOL NORMON 50 mg COMPRIMIDOS RECUBIERTOS EFG | ATENOLOL NORMON 50 mg COMPRIMIDOS RECUBIERTOS EFG , 30 comprimidos | 50 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61492/61492_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61492/61492_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 2001-07-18 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 716415 | 61492 | ATENOLOL NORMON 50 mg COMPRIMIDOS RECUBIERTOS EFG | ATENOLOL NORMON 50 mg COMPRIMIDOS RECUBIERTOS EFG , 60 comprimidos | 50 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61492/61492_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61492/61492_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 2001-07-18 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 716738 | 61493 | ATENOLOL NORMON 100 mg COMPRIMIDOS RECUBIERTOS EFG | ATENOLOL NORMON 100 mg COMPRIMIDOS RECUBIERTOS EFG, 30 comprimidos | 100 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61493/61493_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61493/61493_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 2001-07-18 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 716845 | 61493 | ATENOLOL NORMON 100 mg COMPRIMIDOS RECUBIERTOS EFG | ATENOLOL NORMON 100 mg COMPRIMIDOS RECUBIERTOS EFG, 60 comprimidos | 100 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61493/61493_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61493/61493_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 1997-05-01 | 1 | 1 | 1 | 1997-05-01 | 2001-07-18 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 672287 | 61494 | MOVICOL POLVO PARA SOLUCION ORAL EN SOBRE | MOVICOL POLVO PARA SOLUCION ORAL EN SOBRE , 20 sobres | 13,8 g | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61494/61494_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61494/61494_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37989 | NORGINE DE ESPANA S.L.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-05-19 | View Edit Delete | ||||||||||||
| 677291 | 61494 | MOVICOL POLVO PARA SOLUCION ORAL EN SOBRE | MOVICOL POLVO PARA SOLUCION ORAL EN SOBRE , 30 sobres | 13,8 g | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61494/61494_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61494/61494_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37989 | NORGINE DE ESPANA S.L.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 2010-12-21 | 1 | 2011-05-19 | View Edit Delete | ||||||||||||
| 672220 | 61499 | PLASBUMIN 20% solución para perfusión | PLASBUMIN 20% solución para perfusión, 1 frasco de 100 ml | 200 g/L inyectable perfusión 100 ml | 6 | 1 | 48 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61499/61499_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61499/61499_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 2020-05-25 | 1 | 2023-10-16 | View Edit Delete | ||||||||||||
| 672238 | 61499 | PLASBUMIN 20% solución para perfusión | PLASBUMIN 20% solución para perfusión, 1 frasco de 50 ml | 200 g/L inyectable perfusión 50 ml | 6 | 1 | 48 | 1 frasco de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61499/61499_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61499/61499_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 24324 | INSTITUTO GRIFOLS S.A. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2018-10-29 | View Edit Delete | ||||||||||||
| 762833 | 61509 | TYPHIM VI SOLUCION INYECTABLE | TYPHIM VI SOLUCION INYECTABLE, 1 jeringa precargada de 0,5 ml + 1 aguja | N/A (vacuna) | 22 | 1 | 61 | 1 jeringa precargada de 0,5 ml + 1 aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61509/61509_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61509/61509_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 2023-05-29 | 0 | 2024-02-12 | View Edit Delete | ||||||||||||
| 671990 | 61510 | EFFERALGAN 1 G COMPRIMIDOS EFERVESCENTES | EFFERALGAN 1 G COMPRIMIDOS EFERVESCENTES , 8 comprimidos | 1.000 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61510/61510_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61510/61510_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | NEWLINE PHARMA S.L.U. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 933416 | 61510 | EFFERALGAN 1 G COMPRIMIDOS EFERVESCENTES | EFFERALGAN 1 G COMPRIMIDOS EFERVESCENTES , 20 comprimidos | 1.000 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61510/61510_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61510/61510_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16744 | NEWLINE PHARMA S.L.U. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 2001-08-24 | 1 | 2011-10-18 | 654632 | View Edit Delete | |||||||||||
| 649251 | 61513 | CLORXIL 5 mg/g CREMA | CLORXIL 5 mg/g CREMA , 1 tubo de 200 g | 5 mg/g | 44 | 200 | 21 | 1 tubo de 200 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61513/61513_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61513/61513_p.pdf | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 39653 | LABORATORIOS BOHM S.A. | 1997-03-01 | 1 | 1 | 1 | 1997-03-01 | 1997-03-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 671891 | 61519 | CIPROFLOXACINO QUALIGEN 1MG GOTAS ÓTICAS EN SOLUCIÓN EN ENVASE UNIDOSIS | CIPROFLOXACINO QUALIGEN 1MG GOTAS ÓTICAS EN SOLUCIÓN EN ENVASE UNIDOSIS , 20 envases unidosis de 0,5 ml | 2 mg/ml | 37 | 20 | 51 | 20 envases unidosis de 0,5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61519/61519_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61519/61519_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 45332 | NEURAXPHARM SPAIN S.L.U. | 1997-07-01 | 1 | 1 | 1 | 1997-07-01 | 1997-07-01 | 1 | 2011-10-07 | View Edit Delete |
Page 256 of 1035, showing 20 records out of 20697 total, starting on record 5101, ending on 5120